Developer docs
API playgroundTry for free, no card

Search company profiles

VIBRAINT Inc.

Full company profile

uuid00sm3er

Namestring
VIBRAINT Inc.
Legal namestring
VIBRAINT Inc.
Websiteurl
vibraint.ai
Company typeenum
Private
Founded yearint
2017
Descriptiontext

VIBRAINT Inc. is a privately held Canadian medical device company developing VIBRAINT RehUp, a non-invasive brain-computer interface (BCI) rehabilitation system that targets patients with severe or total paralysis caused by stroke or spinal cord injury. The system detects patient intention to move through EEG-based BCI signal acquisition, interprets that intent using AI, and executes physical movement of the paralyzed limb via robotics, while a virtual reality layer provides multisensory (visual and task-contextual) feedback designed to help the brain re-master motor control. VIBRAINT RehUp is positioned as an investigational device limited by law to investigational use, with the company framing its addressable population as 120 million immobilized people worldwide, 500,000 new spinal cord injury paralyses annually, and roughly one in six stroke survivors losing motor control.

The firm is headquartered in Richmond Hill, Ontario, operating with a five-person core team (CEO Ilia Borishchev, Clinical Lead Dr. Igor Lavrov, CTO Max Aver, QA/RA Lead Michaela Shaw, CFO Alejandro Vivanco) supplemented by six unpaid volunteer advisors drawn from globally recognized neuroscience and rehabilitation institutions. Its go-to-market is sales-led, targeting clinical research partnerships with hospitals, rehabilitation centers, and trial consortia (CanStroke, University of Calgary, Mayo Clinic, Charité Berlin), and recruiting stroke and SCI patients directly for North American clinical studies. Revenue mechanics are undefined: no pricing model is disclosed, no commercial sales exist, and the product remains investigational, placing VIBRAINT firmly in pre-commercial medtech development.

VIBRAINT has accumulated a broad support ecosystem — clinical (CanStroke, Mayo Clinic, UofT H2i), academic (Calgary, York, McMaster, Anáhuac, OCAD, Charité Berlin), financial (Mitacs, Desjardins), and acceleration (MaRS, Innovation Factory, YEDi, OBIO, Synapse, Venture Lab) — and has been recognized through the BCI Award 2021 nomination, the 2021 Ideation Challenge Judges Prize, a GHP award from 2022 to 2024, and the BCI Award 2024 Pitch-Off. No equity funding rounds, revenue figures, M&A activity, or regulatory approvals are publicly disclosed in the available data.

Short descriptiontext

VIBRAINT Inc. develops VIBRAINT RehUp, a non-invasive brain-computer interface system that combines AI, robotics, and virtual reality to help patients paralyzed by stroke or spinal cord injury regain motor control. The investigational medical device is currently in clinical research with hospitals and academic centers in North America and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRichmond Hill, Canada
HQ citystring
Richmond Hill
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
brain-computer interface, neurorehabilitation systems, medical robotics, stroke rehabilitation, spinal cord injury
Industry1 code
PRIMARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
NAICS code1 code
  • Vocational Rehabilitation Services62431
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Neurorehabilitation Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

VIBRAINT RehUp is described as an investigational device limited by law for investigational use, indicating the product is not yet commercially available. The company appears to be in clinical trial phase with future commercial plans for rehabilitation technology deployment through clinical partnerships and direct patient recruitment for studies.

vibraint.ai
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1VIBRAINT RehUp
Description

Brain-controlled rehabilitation system combining non-invasive brain-computer interface (BCI), AI, robotics, and virtual reality (VR) to help paralyzed patients regain motor control.

vibraint.ai
Core offering1 text field

VIBRAINT Inc. develops VIBRAINT RehUp, a brain-controlled rehabilitation system that combines a non-invasive brain-computer interface (BCI) to detect a paralyzed patient's intention to move, AI and robotics to physically execute the movement, and virtual reality (VR) to provide multisensory feedback that helps the brain re-master motor control. The product is currently an investigational device limited to clinical trial use, targeting patients with severe paralysis from stroke or spinal cord injury.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

VIBRAINT Inc. offers a single unified product called VIBRAINT RehUp, which is a groundbreaking brain-controlled rehabilitation system. The system combines a non-invasive brain-computer interface to detect patient intention, artificial intelligence and robotics to execute physical movements, and virtual reality to provide visual feedback that tricks the brain into believing it fully controls the action. This multisensory approach creates an effective rehabilitation experience for patients with paralysis from stroke or spinal cord injury.

Product and service1 record
1VIBRAINT RehUp
CategoryMedical Rehabilitation Device
Description

A brain-computer interface (BCI) rehabilitation system that detects a paralyzed patient's intention to move through neural signals and executes those movements using AI and robotics, while providing multisensory VR feedback so the brain re-learns motor control. It is currently an investigational device limited by law for investigational use, intended for stroke and spinal cord injury patients in clinical trial settings with hospitals, rehabilitation centers, and clinical researchers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
1CanStroke Recovery Trials Platform
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical research partnership with the CanStroke Recovery Trials Platform, led by Dr. Sean Dukelow who serves as Chair of the Steering and Executive Committees. Supports clinical validation of VIBRAINT RehUp technology for stroke rehabilitation.

vibraint.ai
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnership with University of Calgary's Department of Clinical Neuroscience. Dr. Sean Dukelow serves as Professor and Medical Director of Stroke Rehabilitation for the Calgary Stroke Program. Focuses on robotic tools for assessment and rehabilitation of stroke and brain injury patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership with York University. Prof. Lauren E. Sergio holds the York University Research Chair in Brain Health and Gender in Action, is member of Centre for Vision Research, and core member of VISTA and Connected Minds programs.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic research partnership for clinical and rehabilitation technology research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

International academic partnership for neurorehabilitation research collaboration.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Design and innovation partnership with OCAD University for user experience and interface design of rehabilitation technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

International research partnership with Dr. Surjo R. Soekadar, Einstein Professor and Germany's first Professor of Clinical Neurotechnology at Charité Berlin. Dr. Soekadar has been studying neural plasticity and developing BCI technologies since 2005.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Acceleration partnership with MaRS, one of Canada's largest innovation hubs, supporting startup growth and market access.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with U of T Health Innovation Hub. Neil D'Cruz, a Senior Coordinating Mentor at H2i, provides mentorship support. Prof. Morris (Mickey) Milner serves as a founding director connection to the hub.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Ontario-based innovation accelerator providing support. Ing Goping, with 33 years of medical device experience and two successful exits, serves as advisor through this partnership.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Acceleration partnership with Venture Lab for startup support and development.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with OBIO to support Ontario bioscience innovation and commercialization.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

YEDi accelerates and funds high-growth companies in Ontario, providing entrepreneurship support.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Synapse Life Science Consortium supporting life science innovation ecosystem.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical research partnership where Dr. Igor Lavrov, VIBRAINT's Clinical Lead, has been leading research projects since 2017 at Mayo Clinic's Departments of Neurology and Biomedical Engineering, focusing on reorganization of neural circuits in patients with severe motor deficits.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swiss-based digital neurotherapeutics company combining VR, AI, and gamification for stroke and brain injury rehabilitation. Closest direct competitor to VIBRAINT RehUp due to overlapping VR + AI + neurorehab approach and similar stroke/spinal cord injury target population.

TypeEmerging player
Description

BCI company developing a minimally invasive stent-electrode implant for paralysis patients. Comparable as a BCI-focused competitor targeting the same paralysis patient population as VIBRAINT, though using an implanted (rather than non-invasive) approach.

TypeDirect peer
Description

Austrian robotic and computer-assisted rehabilitation device maker for upper and lower extremity therapy in stroke and neuro patients. Comparable as a robotics-driven neurorehabilitation medical device competitor with similar clinical positioning.

TypeBroad incumbent
Description

Elon Musk-backed BCI company developing high-bandwidth brain implants for paralysis and other neurological conditions. Comparable as the most high-profile BCI competitor addressing paralysis, with vastly greater capital but an invasive (implant) approach rather than VIBRAINT's non-invasive EEG-based method.

TypeBroad incumbent
Description

Public wearable exoskeleton and robotic rehabilitation company serving stroke, spinal cord injury, and multiple sclerosis patients. Comparable as a broader, publicly-listed robotic neurorehab incumbent with adjacent technology and overlapping indications.

TypeEmerging player
Description

Shanghai-based rehabilitation robotics company with ArmMotus and other platforms for stroke and neuro rehab. Comparable as a robotic neurorehabilitation device peer with growing global footprint in the same clinical indications.

TypeDirect peer
Description

US-based company offering functional orthoses and rehabilitation devices for stroke survivors and neurological patients. Comparable as a device-based neurorehab company targeting motor recovery in stroke and SCI populations.

8Rehabtronics
TypeEmerging player
Description

Canadian-based neuromodulation and rehabilitation technology company (makers of Prelivia, ReactiStim). Comparable as a Canadian neurorehab device peer with overlapping focus on neurological motor recovery.

9Bionik Laboratories
TypeDirect peer
Description

Robotic rehabilitation technology company with InMotion ARM and InMotion WRIST devices for upper-limb neurologic rehabilitation. Comparable as a robotic neurorehabilitation medical device peer targeting stroke patients.

10Hocoma
TypeDirect peer
Description

Swiss manufacturer of robotic and sensor-based rehabilitation devices (Lokomat, Armeo) for gait and upper-limb therapy. Directly comparable as a robotic neurorehabilitation medical device company serving stroke and spinal cord injury patients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VIBRAINT Inc.

Neurorehabilitation Medical Devicesvibraint.ai

VIBRAINT Inc. develops VIBRAINT RehUp, a non-invasive brain-computer interface system that combines AI, robotics, and virtual reality to help patients paralyzed by stroke or spinal cord injury regain motor control. The investigational medical device is currently in clinical research with hospitals and academic centers in North America and Europe.

What VIBRAINT Inc. does

VIBRAINT Inc. is a privately held Canadian medical device company developing VIBRAINT RehUp, a non-invasive brain-computer interface (BCI) rehabilitation system that targets patients with severe or total paralysis caused by stroke or spinal cord injury. The system detects patient intention to move through EEG-based BCI signal acquisition, interprets that intent using AI, and executes physical movement of the paralyzed limb via robotics, while a virtual reality layer provides multisensory (visual and task-contextual) feedback designed to help the brain re-master motor control. VIBRAINT RehUp is positioned as an investigational device limited by law to investigational use, with the company framing its addressable population as 120 million immobilized people worldwide, 500,000 new spinal cord injury paralyses annually, and roughly one in six stroke survivors losing motor control.

The firm is headquartered in Richmond Hill, Ontario, operating with a five-person core team (CEO Ilia Borishchev, Clinical Lead Dr. Igor Lavrov, CTO Max Aver, QA/RA Lead Michaela Shaw, CFO Alejandro Vivanco) supplemented by six unpaid volunteer advisors drawn from globally recognized neuroscience and rehabilitation institutions. Its go-to-market is sales-led, targeting clinical research partnerships with hospitals, rehabilitation centers, and trial consortia (CanStroke, University of Calgary, Mayo Clinic, Charité Berlin), and recruiting stroke and SCI patients directly for North American clinical studies. Revenue mechanics are undefined: no pricing model is disclosed, no commercial sales exist, and the product remains investigational, placing VIBRAINT firmly in pre-commercial medtech development.

VIBRAINT has accumulated a broad support ecosystem — clinical (CanStroke, Mayo Clinic, UofT H2i), academic (Calgary, York, McMaster, Anáhuac, OCAD, Charité Berlin), financial (Mitacs, Desjardins), and acceleration (MaRS, Innovation Factory, YEDi, OBIO, Synapse, Venture Lab) — and has been recognized through the BCI Award 2021 nomination, the 2021 Ideation Challenge Judges Prize, a GHP award from 2022 to 2024, and the BCI Award 2024 Pitch-Off. No equity funding rounds, revenue figures, M&A activity, or regulatory approvals are publicly disclosed in the available data.

VIBRAINT Inc. firmographics

Firmographics
Name
VIBRAINT Inc.
Legal name
VIBRAINT Inc.
Website
https://vibraint.ai
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
VIBRAINT Inc. develops VIBRAINT RehUp, a non-invasive brain-computer interface system that combines AI, robotics, and virtual reality to help patients paralyzed by stroke or spinal cord injury regain motor control. The investigational medical device is currently in clinical research with hospitals and academic centers in North America and Europe.
Ownership category
akta.pro rank

VIBRAINT Inc. industry classification

Industry
Product category
Neurorehabilitation Medical Devices
NAICS
Vocational Rehabilitation Services (62431)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHSADAIAC
Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise

Keywords

  • Brain-computer interface
  • Neurorehabilitation systems
  • Medical robotics
  • Stroke rehabilitation
  • Spinal cord injury

Where VIBRAINT Inc. is headquartered

Location

Headquarters

HQ city
Richmond Hill
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

VIBRAINT Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Medical Device Sales: VIBRAINT RehUp is described as an investigational device limited by law for investigational use, indicating the product is not yet commercially available. The company appears to be in clinical trial phase with future commercial plans for rehabilitation technology deployment through clinical partnerships and direct patient recruitment for studies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

VIBRAINT Inc. product offering

Product offering

Core offering

VIBRAINT Inc. develops VIBRAINT RehUp, a brain-controlled rehabilitation system that combines a non-invasive brain-computer interface (BCI) to detect a paralyzed patient's intention to move, AI and robotics to physically execute the movement, and virtual reality (VR) to provide multisensory feedback that helps the brain re-master motor control. The product is currently an investigational device limited to clinical trial use, targeting patients with severe paralysis from stroke or spinal cord injury.

Product overview

VIBRAINT Inc. offers a single unified product called VIBRAINT RehUp, which is a groundbreaking brain-controlled rehabilitation system. The system combines a non-invasive brain-computer interface to detect patient intention, artificial intelligence and robotics to execute physical movements, and virtual reality to provide visual feedback that tricks the brain into believing it fully controls the action. This multisensory approach creates an effective rehabilitation experience for patients with paralysis from stroke or spinal cord injury.

Differentiator

Problem solved

Functional benefit

Brands

  • VIBRAINT RehUp: Brain-controlled rehabilitation system combining non-invasive brain-computer interface (BCI), AI, robotics, and virtual reality (VR) to help paralyzed patients regain motor control.

Products and services

  • VIBRAINT RehUp A brain-computer interface (BCI) rehabilitation system that detects a paralyzed patient's intention to move through neural signals and executes those movements using AI and robotics, while providing multisensory VR feedback so the brain re-learns motor control. It is currently an investigational device limited by law for investigational use, intended for stroke and spinal cord injury patients in clinical trial settings with hospitals, rehabilitation centers, and clinical researchers.

Companies that use VIBRAINT Inc.

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

VIBRAINT Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature1 record

VIBRAINT Inc. partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and minor.

  • CanStroke Recovery Trials PlatformcoreStrategic or Co-development PartnerClinical research partnership with the CanStroke Recovery Trials Platform, led by Dr. Sean Dukelow who serves as Chair of the Steering and Executive Committees. Supports clinical validation of VIBRAINT RehUp technology for stroke rehabilitation.
  • University of CalgarycoreStrategic or Co-development PartnerAcademic partnership with University of Calgary's Department of Clinical Neuroscience. Dr. Sean Dukelow serves as Professor and Medical Director of Stroke Rehabilitation for the Calgary Stroke Program. Focuses on robotic tools for assessment and rehabilitation of stroke and brain injury patients.
  • York UniversitycoreStrategic or Co-development PartnerResearch partnership with York University. Prof. Lauren E. Sergio holds the York University Research Chair in Brain Health and Gender in Action, is member of Centre for Vision Research, and core member of VISTA and Connected Minds programs.
  • McMaster UniversityminorStrategic or Co-development PartnerAcademic research partnership for clinical and rehabilitation technology research.
  • Anáhuac University of MexicominorStrategic or Co-development PartnerInternational academic partnership for neurorehabilitation research collaboration.
  • OCAD UniversityminorStrategic or Co-development PartnerDesign and innovation partnership with OCAD University for user experience and interface design of rehabilitation technology.
  • Charité – Universitätsmedizin BerlincoreStrategic or Co-development PartnerInternational research partnership with Dr. Surjo R. Soekadar, Einstein Professor and Germany's first Professor of Clinical Neurotechnology at Charité Berlin. Dr. Soekadar has been studying neural plasticity and developing BCI technologies since 2005.
  • MaRS Discovery DistrictcoreStrategic or Co-development PartnerAcceleration partnership with MaRS, one of Canada's largest innovation hubs, supporting startup growth and market access.
  • University of Toronto Health Innovation Hub (H2i)coreStrategic or Co-development PartnerPartnership with U of T Health Innovation Hub. Neil D'Cruz, a Senior Coordinating Mentor at H2i, provides mentorship support. Prof. Morris (Mickey) Milner serves as a founding director connection to the hub.
  • Innovation FactoryminorStrategic or Co-development PartnerOntario-based innovation accelerator providing support. Ing Goping, with 33 years of medical device experience and two successful exits, serves as advisor through this partnership.
  • Venture LabminorStrategic or Co-development PartnerAcceleration partnership with Venture Lab for startup support and development.
  • Ontario Bioscience Innovation Organization (OBIO)minorStrategic or Co-development PartnerPartnership with OBIO to support Ontario bioscience innovation and commercialization.
  • YEDi (York Entrepreneurship Development institute)minorStrategic or Co-development PartnerYEDi accelerates and funds high-growth companies in Ontario, providing entrepreneurship support.
  • Synapse Life Science ConsortiumminorStrategic or Co-development PartnerPartnership with Synapse Life Science Consortium supporting life science innovation ecosystem.
  • Mayo CliniccoreStrategic or Co-development PartnerClinical research partnership where Dr. Igor Lavrov, VIBRAINT's Clinical Lead, has been leading research projects since 2017 at Mayo Clinic's Departments of Neurology and Biomedical Engineering, focusing on reorganization of neural circuits in patients with severe motor deficits.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

VIBRAINT Inc. competitors and assessment

Company assessment

Direct peers

  • MindMaze: Swiss-based digital neurotherapeutics company combining VR, AI, and gamification for stroke and brain injury rehabilitation. Closest direct competitor to VIBRAINT RehUp due to overlapping VR + AI + neurorehab approach and similar stroke/spinal cord injury target population.
  • Tyromotion: Austrian robotic and computer-assisted rehabilitation device maker for upper and lower extremity therapy in stroke and neuro patients. Comparable as a robotics-driven neurorehabilitation medical device competitor with similar clinical positioning.
  • Saebo: US-based company offering functional orthoses and rehabilitation devices for stroke survivors and neurological patients. Comparable as a device-based neurorehab company targeting motor recovery in stroke and SCI populations.
  • Bionik Laboratories: Robotic rehabilitation technology company with InMotion ARM and InMotion WRIST devices for upper-limb neurologic rehabilitation. Comparable as a robotic neurorehabilitation medical device peer targeting stroke patients.
  • Hocoma: Swiss manufacturer of robotic and sensor-based rehabilitation devices (Lokomat, Armeo) for gait and upper-limb therapy. Directly comparable as a robotic neurorehabilitation medical device company serving stroke and spinal cord injury patients.

Emerging players

  • Synchron: BCI company developing a minimally invasive stent-electrode implant for paralysis patients. Comparable as a BCI-focused competitor targeting the same paralysis patient population as VIBRAINT, though using an implanted (rather than non-invasive) approach.
  • Fourier Intelligence: Shanghai-based rehabilitation robotics company with ArmMotus and other platforms for stroke and neuro rehab. Comparable as a robotic neurorehabilitation device peer with growing global footprint in the same clinical indications.
  • Rehabtronics: Canadian-based neuromodulation and rehabilitation technology company (makers of Prelivia, ReactiStim). Comparable as a Canadian neurorehab device peer with overlapping focus on neurological motor recovery.

Broad incumbents

  • Neuralink: Elon Musk-backed BCI company developing high-bandwidth brain implants for paralysis and other neurological conditions. Comparable as the most high-profile BCI competitor addressing paralysis, with vastly greater capital but an invasive (implant) approach rather than VIBRAINT's non-invasive EEG-based method.
  • Ekso Bionics: Public wearable exoskeleton and robotic rehabilitation company serving stroke, spinal cord injury, and multiple sclerosis patients. Comparable as a broader, publicly-listed robotic neurorehab incumbent with adjacent technology and overlapping indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

VIBRAINT Inc. social profiles

Digital presence

VIBRAINT Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VIBRAINT Inc. leadership team

Management profile

Number of profiles

Profiles5 records

VIBRAINT Inc. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VIBRAINT Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VIBRAINT Inc.

What does VIBRAINT Inc. do?

VIBRAINT Inc. develops VIBRAINT RehUp, a brain-controlled rehabilitation system that combines a non-invasive brain-computer interface (BCI) to detect a paralyzed patient's intention to move, AI and robotics to physically execute the movement, and virtual reality (VR) to provide multisensory feedback that helps the brain re-master motor control. The product is currently an investigational device limited to clinical trial use, targeting patients with severe paralysis from stroke or spinal cord injury.

Is VIBRAINT Inc. a public or private company?

VIBRAINT Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was VIBRAINT Inc. founded?

VIBRAINT Inc. was founded in 2017. It employs 1 to 10 people.

Where is VIBRAINT Inc. based?

VIBRAINT Inc. is headquartered in Richmond Hill, Canada, in the North America region.

How does VIBRAINT Inc. make money?

One revenue line is on record: medical Device Sales.

Who are VIBRAINT Inc.'s main competitors?

Direct peers on record are MindMaze, Tyromotion, Saebo, Bionik Laboratories and Hocoma. Emerging players are Synchron, Fourier Intelligence and Rehabtronics. Broad incumbents are Neuralink and Ekso Bionics.

Does VIBRAINT Inc. have an API?

No public API is recorded for VIBRAINT Inc..

What industry is VIBRAINT Inc. in?

VIBRAINT Inc.'s product category is Neurorehabilitation Medical Devices. Its primary akta.pro industry code is HSADAIAC, Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS). Its NAICS code is 62431 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales